Visby Medical logoCompany profile

Visby Medical

Visby Medical, founded in 2010 and headquartered in San Jose, California, has raised a total of $386 million across multiple funding rounds, including a $100M Series E in March 2022, a $35M follow-up Series E in June 2022, and a $55M Series F in June 2025, achieving a $1 billion valuation. With 251 employees, the company develops portable, instrument-free PCR diagnostics for infectious diseases, serving hospitals and clinics globally. Backed by investors such as Pitango, Cedars Sinai, and Catalio Capital, Visby Medical is expanding production and R&D.

Back to profiles

Quick facts

Total funding
$386 million
Valuation
$1 billion
Founded
2010
Headquarters
San Jose, California
Employees
251

Notable investors

  • Cedars Sinai
  • Catalio Capital
  • Visby Medical is expanding production
  • R&D

Reach buyers like Visby Medical.

The 14-day trial ships every feature, no card required.